Status:
COMPLETED
Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
Mercy Research
Conditions:
Covid19
Pregnancy Related
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Pregnant women are a vulnerable and high-risk population, as COVID-19 is associated with an increased risk preterm birth, cesarean section, and maternal critical care. This study will examine the fact...
Detailed Description
Pregnant women are a vulnerable and high-risk population, as COVID-19 is associated with an increased risk of preterm birth, cesarean section, and maternal intensive care. The objectives of this study...
Eligibility Criteria
Inclusion
- Inclusion Criteria for exposed (SARS-CoV-2 positive) cohort:
- Viable intrauterine pregnancy
- Seroconversion or SARS-CoV-2 IgG antibodies or positive RT-PCR for SARS-CoV-2 during current pregnancy
- Exclusion Criteria for exposed (SARS-CoV-2 positive) cohort:
- No viable intrauterine pregnancy
- No history of SARS-CoV-2 infection during pregnancy
- Inclusion Criteria for unexposed (SARS-CoV-2 negative) cohort:
- Viable intrauterine pregnancy
- No history of SARS-CoV-2 infection prior to pregnancy
- Exclusion Criteria for unexposed (SARS-CoV-2 negative) cohort:
- No viable intrauterine pregnancy
- Detection of SARS-CoV-2 IgG antibodies at enrollment
Exclusion
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2022
Estimated Enrollment :
448 Patients enrolled
Trial Details
Trial ID
NCT04718220
Start Date
March 1 2021
End Date
November 30 2022
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University Medical Center
St Louis, Missouri, United States, 63110